An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in ccRCC and Identifies UCN -Mediated Immune Evasion as a Therapeutic Vulnerability: Evidence from In Vitro and In Vivo Studies.
Saved in:
| Title: | An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in ccRCC and Identifies UCN -Mediated Immune Evasion as a Therapeutic Vulnerability: Evidence from In Vitro and In Vivo Studies. |
|---|---|
| Authors: | Xia, Zhinan1,2 (AUTHOR), Dong, Yu2 (AUTHOR), Zhang, Xin3,4 (AUTHOR), Xia, Wenjiao2,4 (AUTHOR), Wang, Hongru2,5 (AUTHOR), Zhou, Yiyang1,2 (AUTHOR), Qi, Yiming2 (AUTHOR), Liang, Yulan2,3 (AUTHOR), Li, Zhijian1,4 (AUTHOR), Zhang, Yuhang1,5 (AUTHOR), Cui, Zhiming5 (AUTHOR), Wang, Keliang1 (AUTHOR), Zhang, Cheng2 (AUTHOR) |
| Source: | Cancers. May2026, Vol. 18 Issue 9, p1373. 32p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers18091373 |
